Equities

180 Life Sciences Corp

ATNF:NAQ

180 Life Sciences Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.90
  • Today's Change-0.03 / -1.02%
  • Shares traded139.58k
  • 1 Year change-62.77%
  • Beta0.2737
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

180 Life Sciences Corp. is focused on developing new technologies across multiple sectors. The Company is focused on iGaming sector, through its iGaming Technology Platform. The Company also continues to evaluate monetization strategies for its biotechnology assets.

  • Revenue in USD (TTM)0.00
  • Net income in USD-12.55m
  • Incorporated2016
  • Employees4.00
  • Location
    180 Life Sciences Corp3000 El Camino Real, Bldg 4, Ste 200PALO ALTO 94306United StatesUSA
  • Phone+1 (650) 507-0669
  • Fax+1 (302) 636-5454
  • Websitehttps://180lifesciences.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Avenir Wellness Solutions Inc2.86m-4.44m2.73m11.00------0.9531-0.0592-0.05920.038-0.1541.213.9426.16260,363.60-187.30-67.44---160.7170.2965.02-155.03-485.880.013-217.33-----11.2152.8781.42---17.08--
Alternet Systems, Inc.71.97k-869.39k2.75m12.00------38.23-0.00760.00210.0006-0.02710.5397--10.95---651.89-90.16---------1,207.99-782.43---9.92-------56.6243.11------
Asset Entities Inc358.81k-5.65m2.80m11.00--1.16--7.79-1.97-1.970.12570.69530.0953----32,619.09-150.07---161.43-------1,575.30------0.142---19.26---664.22------
Strainsforpains Inc0.00-390.71k2.80m0.00---------0.8747-0.87470.00-5.100.00-------3,555.14-990.82------------------------6.03------
180 Life Sciences Corp0.00-12.55m2.98m4.00---------28.16-28.160.00-0.44390.00----0.00-142.80-42.39-270.23-56.41------------18.20------48.52------
VYRE Network245.59k-545.26k3.05m0.00--0.0039--12.42-0.4621-0.46210.21771.560.08160.61591.96---18.11---23.98--24.34---222.02--0.0015--0.0595---91.43--15.60------
RightsCorp Inc833.42k-1.42m3.05m21.00------3.66-0.0098-0.00980.0059-0.014911.59-------1,979.91-----------170.86-----------6.49--60.53------
Welsis Corp10.00k9.00k3.08m--341.74----307.610.00330.00330.0036-0.02020.4178------37.60----------90.00-----16.30--------4.02------
Quantgate Systems Inc24.59k-222.99k3.12m0.00--0.2111--126.69-0.0066-0.00660.00070.04910.0089--0.5384---8.06---14.32-------906.83------0.2034--35.64---11.11------
Auddia Inc0.00-8.84m3.12m13.00--0.3262-----8.26-8.260.001.690.00----0.00-137.56-167.44-194.09-----287.81---6,751.12---11.550.00-------27.69--5.10--
Lytus Technologies Holdings Ptv Ltd21.36m287.67k3.13m3.005.650.23681.980.14650.29730.297326.487.09------7,121,260.00--3.79--7.6421.54--3.0626.30---0.31290.1465--12.39--112.25------
Treasure Global Inc22.07m-6.59m3.17m25.00--0.179--0.1436-13.01-13.0122.332.024.1499.30270.48882,673.60-123.68---401.22--3.70---29.85--1.04-6.710.0138---68.21--43.84------
Ubiquitech Software Corp-100.00bn-100.00bn3.18m2.00---------------0.0018------------------------0.2022--1.36--8,230.16---14.20------
Tianrong Internet Products and Srvcs Inc0.00-263.91k3.22m0.00---------0.0031-0.00310.00-0.00870.00-------334.06-----------------32.38---------120.66------
APPlife Digital Solutions Inc6.97k-5.05m3.22m1.00------461.67-0.0452-0.04520.00007-0.01390.04362.01--6,970.00-3,157.12-1,228.69-----838.16-61.26-72,461.98-22,529.880.0274-9.70-----85.11---44.44------
OLB Group Inc22.62m-25.15m3.33m26.00--0.4019--0.147-15.91-15.9113.644.600.8403--22.66870,091.10-93.29-31.01-125.41-35.0127.3327.80-111.03-40.08----0.0359--0.667327.65-184.58------
Data as of Nov 08 2024. Currency figures normalised to 180 Life Sciences Corp's reporting currency: US Dollar USD

Institutional shareholders

0.69%Per cent of shares held by top holders
HolderShares% Held
Tower Research Capital LLCas of 30 Jun 20246.27k0.61%
BlackRock Fund Advisorsas of 30 Jun 2024750.000.07%
BlackRock Financial Management, Inc.as of 30 Jun 202422.000.00%
RBC Dominion Securities, Inc.as of 30 Jun 202411.000.00%
BofA Securities, Inc.as of 30 Jun 20249.000.00%
Bank of America, NA (Private Banking)as of 30 Jun 20243.000.00%
Qube Research & Technologies Ltd.as of 30 Jun 20242.000.00%
JPMorgan Securities LLC (Investment Management)as of 30 Jun 20241.000.00%
Semmax Financial Advisors, Inc.as of 30 Jun 20241.000.00%
Wells Fargo Bank, NA (Private Banking)as of 30 Jun 20240.000.00%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.